PMC:7293470 / 4323-4612 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T137","span":{"begin":16,"end":19},"obj":"GO:0042611"},{"id":"T138","span":{"begin":123,"end":128},"obj":"SP_6;NCBITaxon:9606"},{"id":"T139","span":{"begin":134,"end":140},"obj":"SO:0000417"},{"id":"T140","span":{"begin":175,"end":181},"obj":"SO:0000417"},{"id":"T141","span":{"begin":183,"end":189},"obj":"MOP:0000779"},{"id":"T64396","span":{"begin":16,"end":19},"obj":"GO:0042611"},{"id":"T74610","span":{"begin":123,"end":128},"obj":"SP_6;NCBITaxon:9606"},{"id":"T78710","span":{"begin":134,"end":140},"obj":"SO:0000417"},{"id":"T50125","span":{"begin":175,"end":181},"obj":"SO:0000417"},{"id":"T69070","span":{"begin":183,"end":189},"obj":"MOP:0000779"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T56","span":{"begin":16,"end":19},"obj":"Body_part"},{"id":"T57","span":{"begin":166,"end":169},"obj":"Body_part"}],"attributes":[{"id":"A56","pred":"fma_id","subj":"T56","obj":"http://purl.org/sig/ont/fma/fma84079"},{"id":"A57","pred":"fma_id","subj":"T57","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":215,"end":224},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_2000106"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T69","span":{"begin":123,"end":128},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T70","span":{"begin":201,"end":203},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T71","span":{"begin":207,"end":214},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T75","span":{"begin":129,"end":131},"obj":"Chemical"},{"id":"T76","span":{"begin":170,"end":172},"obj":"Chemical"},{"id":"T77","span":{"begin":207,"end":214},"obj":"Chemical"}],"attributes":[{"id":"A75","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A76","pred":"chebi_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T2","span":{"begin":197,"end":203},"obj":"GlycoEpitope"}],"attributes":[{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/AN0706"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}

{"project":"LitCovid-PubTator","denotations":[{"id":"197","span":{"begin":16,"end":19},"obj":"Gene"},{"id":"207","span":{"begin":197,"end":200},"obj":"Gene"},{"id":"209","span":{"begin":123,"end":128},"obj":"Species"}],"attributes":[{"id":"A197","pred":"tao:has_database_id","subj":"197","obj":"Gene:3107"},{"id":"A207","pred":"tao:has_database_id","subj":"207","obj":"Gene:4340"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ility) required MHC-matched recipients [7]. Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recip"}